controlled substance

Secretary of State Orders Emergency Classification of Xylazine aka “Tranq” as Schedule III Controlled Substance

Delaware Secretary of State Jeff Bullock has placed xylazine, also known as “Tranq”— a non-opioid drug used primarily in veterinary medicine—in Schedule III of the Uniform Controlled Substance Act. Tranq has been used increasingly as an additive in opioid abuse to create a “zombie-like” condition for users. Secretary Bullock’s actions follow a recommendation from the […]




controlled substance

A U.K. option for a controlled substance

TPI Enterprises, an Australian poppy processor, enters the restrictive British codeine market via a contract with Sterling Pharma Solutions




controlled substance

Secretary of State Announces Medical License and Controlled Substance Registration Suspensions

Secretary of State Jeffrey Bullock has suspended the Delaware medical license and controlled substance privileges of Gregory Villabona, in light of allegations of unprofessional conduct related to the prescription and distribution of opioid medications.




controlled substance

Secretary of State Announces Medical License and Controlled Substance Privileges Suspension

Secretary of State Jeffrey Bullock has suspended the Delaware medical license and controlled substance prescribing privileges of Ifeanyi Udezulu for repeatedly failing to adhere to state regulations for the safe prescribing of opioid medications.




controlled substance

Patients of Sussex County Doctor Whose Medical License, Controlled Substance Registration Revoked Getting Resources

DOVER (May 9, 2019) – On May 8, 2019, the medical license and controlled substance registrations of Nihar B. Gala, MD, were permanently revoked by the Delaware Board of Medical Licensure and Discipline. The revocation was a result of allegations of unprofessional conduct related to the prescription of opioids to a patient at high risk […]




controlled substance

Patients of NCCo Doctor Whose Medical License, Controlled Substance Registration Suspended Urged to Seek Ongoing Care

DOVER (Aug. 1, 2019) – On July 30, 2019, the medical license and controlled substance registration of Damon Cary, MD, were suspended temporarily by the Delaware Board of Medical Licensure and Discipline. The suspension was the result of a request made by the Delaware Attorney General’s Office following investigations into the prescribing and treatment practices […]




controlled substance

Former U.S. Official Pleads Guilty to Abusive Sexual Contact and Possession of a Firearm While Unlawfully Using a Controlled Substance

Andrew Warren, 42, a former official with the Central Intelligence Agency (CIA), pleaded guilty today to a two-count criminal information charging him with abusive sexual contact and unlawful use of cocaine while possessing a firearm.



  • OPA Press Releases

controlled substance

Senior U.S. District Court Judge Pleads Guilty to Possession of Controlled Substances and Conversion of Government Property

Senior U.S. District Judge Jack T. Camp Jr., pleaded guilty today in U.S. District Court in Atlanta to possession of controlled substances and conversion of government property.



  • OPA Press Releases

controlled substance

United States Files Lawsuit Against PharMerica Corporation for Violations of the False Claims Act and the Controlled Substances Act

The United States has filed suit against PharMerica Corp. in the U.S. District Court for the Eastern District of Wisconsin. The lawsuit alleges that PharMerica violated the False Claims Act and the Controlled Substances Act by dispensing controlled drugs without valid prescriptions and causing claims for illegally dispensed drugs to be submitted to the Medicare program.



  • OPA Press Releases

controlled substance

Just a Decade Later, DEA Reopens Comment Period for Electronic Prescriptions for Controlled Substances

By Karla L. Palmer




controlled substance

A U.K. option for a controlled substance

TPI Enterprises, an Australian poppy processor, enters the restrictive British codeine market via a contract with Sterling Pharma Solutions